Early restaging whole-body 18F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma

被引:0
作者
Ruoh-Fang Yen
Tony Hsiu-Hsi Chen
Lai-Lei Ting
Kai-Yuan Tzen
Mei-Hsiu Pan
Ruey-Long Hong
机构
[1] National Taiwan University Hospital and National Taiwan University College of Medicine,Department of Nuclear Medicine
[2] National Taiwan University College of Public Health,Institute of Preventive Medicine
[3] National Taiwan University Hospital and National Taiwan University College of Medicine,Department of Oncology, Division of Radiation Oncology
[4] National Taiwan University Hospital and National Taiwan University College of Medicine,Department of Oncology
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2005年 / 32卷
关键词
Nasopharyngeal carcinoma; Induction chemotherapy; Whole-body ; F-FDG PET; Therapeutic response; Survival analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1152 / 1159
页数:7
相关论文
共 172 条
[1]  
Huang DP(1990)Epidemiology of nasopharyngeal carcinoma Ear Nose Throat J 69 222-225
[2]  
Oh JL(2003)Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer Ann Oncol 14 564-569
[3]  
Vokes EE(2002)Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation J Clin Oncol 20 1845-1852
[4]  
Kies MS(2001)Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma J Clin Oncol 19 4305-4313
[5]  
Mittal BB(1995)Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy? The EC PET Oncology Concerted Action and the EORTC PET Study Group Eur J Cancer 31A 1924-1927
[6]  
Witt ME(1999)Measurement of clinical and subclinical tumour response using [ Eur J Cancer 35 1773-1782
[7]  
Weichselbaum RR(2001)F]-fluorodexoyglucose and positron emission tomography: review and 1999 EORTC recommendation J Clin Oncol 19 414-419
[8]  
Rischin D(2002)Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([ Ann Oncol 13 1356-1363
[9]  
Corry J(2002)F]FDG) after first-line chemotherapy in non-Hodgkin’s lymphoma: is[ J Nucl Med 43 1018-1027
[10]  
Smith J(1995)F]FDG-PET a valid alternative to conventional diagnostic methods? J Clin Oncol 13 1470-1477